When should hyperuricemia be treated?

When to Treat Uric Acid Levels

Do not treat asymptomatic hyperuricemia (uric acid >6.8 mg/dL without gout symptoms), but strongly treat patients with established gout based on flare frequency and disease severity. 1

Strong Indications for Urate-Lowering Therapy (ULT)

The 2020 ACR guidelines provide clear, evidence-based thresholds for when to initiate treatment:

Definite Treatment (Strong Recommendations)

• Subcutaneous tophi present (any number) - High certainty evidence 1
• Radiographic damage from gout on any imaging modality - Moderate certainty evidence 1
• Frequent gout flares (≥2 per year) - High certainty evidence 1

Consider Treatment (Conditional Recommendations)

• Infrequent flares (>1 lifetime flare but <2/year) - Moderate certainty evidence 1
• First gout flare with any of these high-risk features 1:
  • CKD stage >3
  • Serum uric acid >9 mg/dL
  • History of urolithiasis (kidney stones)

Do NOT Treat Asymptomatic Hyperuricemia

The evidence strongly recommends against treating asymptomatic hyperuricemia (uric acid >6.8 mg/dL without any gout history), even with comorbidities like CKD, cardiovascular disease, or hypertension 1. Here's why:

• The number needed to treat is 24 patients for 3 years to prevent a single gout flare 1
• Only 20% of patients with uric acid >9 mg/dL develop gout within 5 years 1
• The risks and costs of long-term ULT outweigh benefits in this population 1
• This applies even if MSU crystals are detected on ultrasound or dual-energy CT without symptoms 1

Recent research confirms this approach - randomized trials show no clear cardiovascular or renal benefit from treating asymptomatic hyperuricemia 2, 3, 4.

First Gout Flare: Generally Wait

For patients experiencing their first gout flare without high-risk features, conditionally recommend against starting ULT 1. The rationale is that many patients may not have recurrent flares, making immediate lifelong therapy premature.

However, make exceptions and start ULT after the first flare if:

• CKD stage >3 (higher risk of gout progression and limited treatment options for flares) 1
• Serum uric acid >9 mg/dL (much higher likelihood of disease progression) 1
• History of kidney stones (ULT reduces stone recurrence) 1

Treatment Target Once Initiated

When ULT is indicated, target serum uric acid:

• <6 mg/dL for standard gout management 5
• <5 mg/dL for severe gout (tophi, chronic arthropathy, frequent attacks) to accelerate crystal dissolution 5
• Avoid long-term levels <3 mg/dL 5

First-Line Agent

Allopurinol is the strongly recommended first-line agent for all patients, including those with moderate-to-severe CKD 1. Start low (≤100 mg/day, lower in CKD) and titrate up every 2-4 weeks to reach target uric acid levels 1, 5.

Common Pitfalls to Avoid

• Don't treat the number alone - asymptomatic hyperuricemia does not warrant treatment regardless of how high the uric acid level is (unless >9 mg/dL with first flare)
• Don't withhold treatment in established gout - patients with tophi or frequent flares have strong evidence for benefit
• Don't start at high doses - begin allopurinol at ≤100 mg/day to reduce flare risk and hypersensitivity reactions 1
• Don't forget flare prophylaxis - use colchicine or low-dose NSAID when initiating ULT 5